Market revenue in 2023 | USD 18.0 million |
Market revenue in 2030 | USD 42.0 million |
Growth rate | 12.9% (CAGR from 2023 to 2030) |
Largest segment | Ferric carboxymaltose |
Fastest growing segment | Ferric Carboxymaltose |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Iron Dextran, Iron Sucrose, Ferric Carboxymaltose |
Key market players worldwide | AbbVie Inc, Civitas Resources Inc Ordinary Shares, Daiichi Sankyo Co Ltd, Sanofi SA, CSL Ltd, COSMOS Pharmaceutical Corp, Zydus Lifesciences, Rockwell Medical Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous iron drugs market will help companies and investors design strategic landscapes.
Ferric carboxymaltose was the largest segment with a revenue share of 54.44% in 2023. Horizon Databook has segmented the Mexico intravenous iron drugs market based on iron dextran, iron sucrose, ferric carboxymaltose covering the revenue growth of each sub-segment from 2018 to 2030.
According to NCBI data, CKD has become a serious health burden in Mexico. Due to an unfavorable healthcare reimbursement framework, the treated End-stage Renal Disease (ESRD) rate was 281 per million population for insured people and 130 per million population for uninsured people.
Hence, such factors are expected to drive the market in the country. Based on Halfway National Health and Nutrition Survey, the prevalence of anemia among Mexican children was 26.9% (aged 1-4 years), 12.5% (5-11 years), and 9.6% (12-19 years), which is further driving the regional market.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico intravenous iron drugs market , including forecasts for subscribers. This country databook contains high-level insights into Mexico intravenous iron drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account